上个星期，FDA有条件的批准了更年期综合症上的应用，要求进行另外的临床试验来评估可能引起的肝和心血管的不良反应。
Last week, the FDA granted the menopause application conditional approval, saying another clinical trial would be required to assess possible liver and cardiovascular side effects.
目的：探讨艾司洛尔对支撑喉镜引起的心血管反应的预防作用。
Objective: to study the cardiovascular protective effect by Esmolol during anesthesia for excision of vocal nodules under suspension laryngoscopy.
结论气管插管时，艾司洛尔即可减轻病人的心血管反应，又可抑制插管刺激引起的大脑皮层兴奋性的增加。
Conclusion Esmolol not only attenuated haemodynamic to orotracheal intubation, but also prevented BIS arousal reactions in patients anaesthetized with propofol.
应用推荐